Velan Capital is a healthcare-focused investment firm specializing in undervalued, late-stage pharmaceutical companies. The firm targets public development-stage and commercial-stage companies that are generating revenue, preparing for commercial launch, or operating in late stages of development. Velan Capital typically engages in post-IPO equity rounds, leveraging their expertise to identify and invest in promising opportunities within the specialty pharmaceutical industry.
Notable portfolio companies include enVVeno Medical, Heron Therapeutics, Kiora Pharmaceuticals, and Outlook Therapeutics, with substantial investments ranging from $15 million to $65 million. Velan Capital is known for its active investment approach, working closely with management teams and board directors to support growth and build successful businesses. This hands-on strategy aims to cultivate attractive outcomes and drive value creation within their portfolio.
Velan Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
